Clinical Trials Logo

Clinical Trial Summary

Patient therapeutic education (PTE) has become "a must" in the modern management of chronic diseases. Its main objective is to improve compliance with treatment and the application of preventive measures. The main goal of this study is to assess the influence of the therapeutic education program on the perception of the disease in patients with autoimmune myasthenia. Secondary objectives are to assess quality of life, patient satisfaction of the PTE program, the acquisition of therapeutic goals and the influence of therapeutic education on the evolution of autoimmune myasthenia Study team hypothesize that therapeutic education could improve the patient's perception of myasthenia and its quality of life. By improving patient's adherence to treatments and his knowledge of the disease, it could also improve the evolution of myasthenia gravis. Study team suppose that PTE program can reduce the absenteeism at work, the number and duration of hospitalizations, particularly those in intensive care units.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04714658
Study type Interventional
Source University Hospital, Strasbourg, France
Contact
Status Not yet recruiting
Phase N/A
Start date January 22, 2021
Completion date May 22, 2025